Sat, Feb 28, 2015, 10:00 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • omkarbhutani omkarbhutani Jan 30, 2013 9:29 PM Flag

    BioTuesdays: Immune-EpiCept to get multiple clinical shots on goal


    It looks like EPCT will contribute all its (our) shares in exchange for 22.5% of the shares in the new company. So, we will get new shares in Immune Technologies (the combined company) when this is completed. No way to tell what they will be worth and what the future holds- will just have to hope that this gives them the funds to continue their trials and they find someone to partner with to finish the Phase III trials and FDA New Drug application for Amiket.

    Sentiment: Strong Buy

    This topic is deleted.
1.79-0.01(-0.55%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.